Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127495181 | 12749518 | 1 | I | 20160425 | 20160915 | 20160915 | PER | US-ASTELLAS-2016US016084 | ASTELLAS | 0.00 | M | Y | 0.00000 | 20160915 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127495181 | 12749518 | 1 | PS | XTANDI | ENZALUTAMIDE | 1 | Unknown | U | 203415 | 160 | MG | CAPSULE | QD | ||||||
127495181 | 12749518 | 2 | SS | LUPRON | LEUPROLIDE ACETATE | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN | ||||||||
127495181 | 12749518 | 3 | C | DOXYCYCLINE HYDROCHLORIDE | DOXYCYCLINE HYDROCHLORIDE | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | CAPSULE | ||||||||
127495181 | 12749518 | 4 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | TABLET | ||||||||
127495181 | 12749518 | 5 | C | NITROFURANTIN | NITROFURANTOIN | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | CAPSULE | ||||||||
127495181 | 12749518 | 6 | C | OXYCODONE WITH APAP | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | TABLET | ||||||||
127495181 | 12749518 | 7 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | TABLET | ||||||||
127495181 | 12749518 | 8 | C | SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | TABLET | ||||||||
127495181 | 12749518 | 9 | C | VESICARE | SOLIFENACIN SUCCINATE | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127495181 | 12749518 | 1 | Hormone-refractory prostate cancer |
127495181 | 12749518 | 2 | Product used for unknown indication |
127495181 | 12749518 | 3 | Product used for unknown indication |
127495181 | 12749518 | 4 | Product used for unknown indication |
127495181 | 12749518 | 5 | Product used for unknown indication |
127495181 | 12749518 | 6 | Product used for unknown indication |
127495181 | 12749518 | 7 | Product used for unknown indication |
127495181 | 12749518 | 8 | Product used for unknown indication |
127495181 | 12749518 | 9 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127495181 | 12749518 | Heart rate increased | |
127495181 | 12749518 | Hot flush | |
127495181 | 12749518 | Myalgia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127495181 | 12749518 | 1 | 201603 | 0 |